Effects of IL-2 on the myocardium. Participation of the sympathetic system

Journal of Molecular and Cellular Cardiology

Volumn 28, Issue 12, 1996, Pages 2457-2465

  Sterin Borda, Leonor ^a   Perez Leiros, Claudia ^a   Borda, Enri S ^a   De Bracco, María M E ^b  

^a Centre de Estudios Farmacologicos y Botanicos   (Argentina)

^b INST DE INVEST HEMATOLOGICAS   (Argentina)

Author keywords

Cytokines and contractility; Interleukin 2; Interleukin 2 and cAMP; Myocardial adrenoceptors

Indexed keywords

4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE; BETA ADRENERGIC RECEPTOR; CATECHOLAMINE; COCAINE; COLCHICINE; CYCLIC AMP; INTERLEUKIN 2; ISOPRENALINE; NORADRENALIN; OXIDOPAMINE; PHENTOLAMINE; PROPRANOLOL;

ADRENERGIC SYSTEM; ANIMAL TISSUE; ARTICLE; CATECHOLAMINE RELEASE; CELL INFILTRATION; CHEMICAL SYMPATHECTOMY; CONTROLLED STUDY; DRUG BINDING; HEART ATRIUM; HEART DISEASE; HEART MUSCLE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE FIBER MEMBRANE; IMMUNE SYSTEM; INFLAMMATORY CELL; INOTROPISM; MALE; MEMBRANE BINDING; NONHUMAN; NORADRENALIN RELEASE; PRESYNAPTIC NERVE; PRIORITY JOURNAL; RAT; SECOND MESSENGER;

EID: 0030450323     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1996.0238     Document Type: Article

References (39)

1. ARZT E, BURIC R, STELZER G, STALLA J, SAUER J, RENNER U, STALLA GK, 1993. Interleukin involvement in anterior pituitary cell growth regulation: effects of IL-2 and IL-6. Endocrinology 132: 459-467.
2. BORDA ES, PEREZ-LEIROS C, STERIN-BORDA L, DE BRACCO MME, 1991. Cholinergic response of isolated rat atria to recombinant interferon gamma (IFN). J Neuroimmunol 32: 55-59.
3. BORDA ES, STERIN-BORDA L, RODRIGUEZ M, DE BRACCO MME, 1994. Cholinoceptor activation subserving the effects of IFN on the contractility of rat ileum. Med Inflamm 3: 453-458.
4. BROWN BL, ALBANO JD, ELKINS RP, SGHERZI AM, 1971. Simple and selective saturation assay method for the measurement of adenosine 3′,5′-cyclic monophosphate. Biochem J 121: 561-562.
5. BURGEN ASV, IVERSEN LL, 1965. Inhibition of nor-adrenaline uptake by sympathomimetic amines in the rat isolated heart. Br J Pharmacol 25: 34-42.
6. CHUNG MK, GULIK T, ROTONDO RT, SCHREINER GF, LANGE LG, 1990. Mechanism of cytokine inhibition of β-adrenergic agonist stimulated cAMP in rat cardiac myocytes. Impairment of signal transduction. Circ Res 67:753-763.
7. DE BRACCO MME, STERIN-BORDA L, FINIASZ M, CANGIANI S, STORINO R, DIEZ C, BORDA E, 1986. Modification of the contractile activity of isolated rat atria by T4 lymphocytes from patients with Chagas' disease. Effect of soluble factors. Intl J Immunopharmacol 8: 645-649.
8. DE BRACCO MME, FINK SB, FINIASZ MR, BORDA ES, STERIN-BORDA L, 1991. Positive inotropic effect of in terleukin-2. Role of phospholipases and protein kinase C. Intl J Immunopharmacol 13: 509-515.
9. DE BRACCO MME, BORDA ES, STERIN-BORDA L, 1995. Opposite effects of interleukin-2 (IL-2) and interferon gamma (IFN) on rat atria contractility. Acta Physiol Pharmacol Latinoam 45: 165-176.
10. FARRAR WL, ANDERSON WB, 1985. Interleukin-2 stimulates association of protein kinase C with plasma membrane. Nature 315: 233-235.
11. FINK S, FINIASZ M, STERIN-BORDA L, BORDA E, DE BRACCO MME, 1989. Stimulation of heart contractility by supernatants from lectin activated lymphocytes. Role of interleukin-2. Intl J Immunopharmacol 11: 367-370.
12. FINKEL MS, ODDIS CV, JACOB TD, WATKINS SC, HATTLER BG, SIMMONS RL, 1992. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 257:387-389.
13. GHOSH A, GREENBERG ME, 1995. Calcium signaling in neurons: molecular mechanisms and cellular consequences. Science 268: 239-247.
14. GULIK T, CHUNG MK, PIEPER SJ, SCHREINER GF, LANGE LG, 1988. Immune cytokine inhibition of β-adrenergic agonist stimulated cAMP in cardiac myocytes. Biochem Biophys Res Commun 150: 1-9.
15. GOODMAN DP, RASMUSSEN H, DI BELLA F, GUTHROW CB, 1970. Cyclic adenosine 3′,5′ monophosphate stimulated phosphorylation of isolated microtubule subunits. Proc Natl Acad Sci USA 67: 652-659.
16. KARANTH S, MCCANN SM, 1991. Anterior pituitary control by interleukin 2. Proc Natl Acad Sci USA 88: 2961-2965.
17. KARIN M, 1992. Signal transduction from cell surface to nucleus in development and disease. FASEB J 6: 2581-2590.
18. KROGEL AH, TRAVIS WD, STEIG RG, ROSEMBERG SA, ROBERTS WC, 1990. Myocarditis or acute myocardial infarction associated with interleukin-2 therapy for cancer. Cancer 66: 1513-1516.
19. LEE RE, LOTZE MT, SKIBBER JM, TUCKER E, BONOW RD, OGNIBENE FP, CARRASQUILLO JA, SHELHAMER JH, PARRILLO JE, ROSENBERG SA, 1989. Cardiorespiratory effects during recombinant interleukin 2. J Clin Oncol 7: 7-20.
20. LIMAS CCJ, 1978. Reduced number of beta adrenergic receptors in the myocardium of spontaneously hypertensive rats. Biochem Biophys Res Commun 83:710-712.
21. LOWRY OH, ROSEBROUGH NJ, FARR AL, RANDALL RJ, 1951. Protein measurement by the Folin phenol reagent. J Biol Chem 193: 265-275.
22. MANN H, WARD JH, SAMLOWSKI WE, 1990. Vascular leak syndrome associated with interleukin 2. Chest radiographic manifestations. Radiology 176: 191-194.
23. MILLS G, MAY C, MCGiLL M, FUNG M, BAKER M, SUTHERLAND R, GREENE WC, 1990. Interleukin 2-induced tyrosine phosphorylation. J Biol Chem 265: 3561-3567.
24. OGNIBENE FP, ROSENBERG SA, LOTZE M, SKIBBER H, PARKER MM, SHELHAMER JH, PARRILLO JE, 1988. Interleukin 2 administration causes irreversible hemodynamic changes and left ventricular dysfunction similar to those seen in septic shock. Chest 94: 750-754.
25. PEREZ LEIROS C, STERIN-BORDA L, BORDA ES, 1988. Lymphocyte infiltration induces dysfunction in autoimmune myocarditis: role of SRS-A. J Mol Cell Cardiol 20: 149-158.
26. ROSENSTEIN M, ETTINHAUSEN SE, ROSENBERG SA, 1986. Extravasation of intravascular fluid mediated by the systemic administration of recombinant interleukin 2. J Immunol 137: 1735-1742.
27. SCHECHTER D, NAGLER A, ACKERSTEIN A, NASSAR H, ADMON D, NAPARSTEK E, REIN AJJT, 1992. Recombinant-interleukin 2 and interferon alpha immunotherapy following autologous bone marrow transplantation. Cardiology 80: 168-171.
28. SCHWARTZ JH, 1979. Axonal transport: components, mechanisms and specificity. Annu Rev Neurosci 2: 467-504.
29. SOBOTKA PA, MCMANNIS J, FISHER RI, STEIN DG, THOMAS JX, 1990. Effect of IL-2 on cardiac function of isolated rat heart. J Clin Invest 86: 845-850.
30. STEINBERG SF, GOLDBERG M, RYBIN VO, 1995. Protein kinase C isoform diversity in the heart. J Mol Cell Cardiol 27: 141-153.
31. STERIN-BORDA L, BORDA ES, FINK SB, DE BRACCO MME, 1983. Effect of phytohemagglutinin-stimulated human lymphocytes on isolated rat atria. Participation of lipoxygenase products of arachidonic acid metabolism. Naunyn Schmied Arch Pharmacol 324: 58-63.
32. STERIN-BORDA L, CANTORE M, PASCUAL J, BORDA E, COSSIO P, ARANA R, PASSERON S, 1986. Chagasic IgG binds and interacts with cardiac β-adrenoceptor coupled adenylate cyclase system. Intl J Immunopharmacol 8:581-588.
33. STJARNE G, WENNMALM A, 1971. Quantitative stimulation of secretion and reuptake adrenergic transmitter in the rabbit heart. Acta Physiol Scand 81: 266-288.
34. TRENDELEMBURG U, 1963. Supersensitivity and subsensitivity to sympathomimetic amines. Pharmacol Rev 15:225-276.
35. UNGUREANU-LONGROIS D, BALLIGAND JL, KELLY RA, SMITH TW, 1995. Myocardial contractile dysfunction in the systemic inflammation response syndrome: role of a cytokine-inducible nitric oxide synthase in cardiac myocytes. J Mol Cell Cardiol 27: 155-167.
36. VAN ROSSUM JM, 1963. Cumulative dose-response curves. II. Technique for the making of dose-response curves on isolated organs and the evaluation of drug parameters. Arch Intl Pharmacodyn Thér 143: 299-305.
37. WAMSLEY JK, 1992. Transport of receptors. Mol Neurobiol 6:313-321.
38. WARBANOW W, WOLLENBERGER A, 1979. Mechanical responses of culture pre-and neonatal myocytes. J Mol Cell Cardiol 11 [Suppl. 1]: 64-70.
39. WEIGENT DA, BLALOCK JE, 1995. Associations between the neuroendocrine and immune systems. J Leukoc Biol 137: 137-150.